Evidence map›Paper›PMID 35492562›Full record

ArticleRSC advances2019

A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.

Meiling Su, Yanming Xia, Yajing Shen, Weili Heng, Yuanfeng Wei, Linghe Zhang, Yuan Gao, Jianjun Zhang, Shuai Qian

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Development of spray-dried amorphous solid dispersions of tadalafil using glycyrrhizin for enhanced dissolution and aphrodisiac activity in male rats.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Meiling SuSchool of Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China amicute@163.com +86 25 83379418 +86 25 83379418.
Yanming XiaSchool of Traditional Chinese Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China silence_qs@163.com +86 139 1595 7175.
Yajing ShenSchool of Traditional Chinese Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China silence_qs@163.com +86 139 1595 7175.
Weili HengSchool of Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China amicute@163.com +86 25 83379418 +86 25 83379418.
Yuanfeng WeiSchool of Traditional Chinese Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China silence_qs@163.com +86 139 1595 7175.
Linghe ZhangDepartment of Chemistry, Smith College Northampton MA 01063 USA.
Yuan GaoSchool of Traditional Chinese Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China silence_qs@163.com +86 139 1595 7175.
Jianjun ZhangSchool of Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China amicute@163.com +86 25 83379418 +86 25 83379418.
Shuai QianSchool of Traditional Chinese Pharmacy, China Pharmaceutical University Nanjing 211198 P. R. China silence_qs@163.com +86 139 1595 7175.ORCID https://orcid.org/0000-0003-1961-4128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tadalafil and repaglinide, categorized as BCS class II drugs, have low oral bioavailabilities due to their poorly aqueous solubilities and dissolutions. The aim of this study was to enhance the dissolution of tadalafil and repaglinide by co-amorphization technology and evaluate the storage and compression stability of such coamorphous system. Based on Flory-Huggins interaction parameter (

Identifiers

PMID35492562
PMCPMC9048229

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.